The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating ...

Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, to ...

Gen Z grads are slamming degrees as worthless—but Fortune 500 boss, Doina Ionescu, says her MBA was the best investment ...

The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...

That challenge, of finding or building good, useable data sets, is also one of the biggest differentiators in an increasingly ...

Company scales leadership to accelerate growth and reinforce market position as the leader in AI-powered life sciences ...

The pending deal was rumored overnight after a report from the Financial Times, spurring analysts to speculate that if true, ...

AQR Capital's Q1'25 portfolio hits $97.07B, with top picks in AAPL, NVDA, & AMZN. Active portfolio adjustments show a ...

The Israel-Iran clash seemingly has no end in sight — a prospect that does not seem to be panicking the markets.

Fat steers and heifers filled the pens at the Finney County Fairgrounds in the early morning hours of June 3, waiting to be ...